Valuation CSPC Pharmaceutical Group Limited

Stocks

Market Closed - Hong Kong S.E. 04:08:48 2026-08-19 EDT			5-day change	1st Jan Change
8.685 ^HKD	-1.31%		-0.17%	+3.02%

08-18	CSPC Pharma Unit's Breast Cancer Drug Application Granted Priority Review in China	MT
08-12	CSPC Pharmaceutical Group Limited Provides Update on the Collaboration, Option and License Agreement with Astrazeneca for the Development of siRNA Drugs	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	100,932	97,707	86,022	55,169	96,380	99,296	-	-
Change	-	-3.19%	-11.96%	-35.87%	74.7%	3.02%	-	-
Enterprise Value (EV) ¹	89,633	86,241	72,284	46,931	86,710	88,954	86,208	83,009
Change	-	-3.79%	-16.18%	-35.07%	84.76%	2.59%	-3.09%	-3.71%
P/E	14.7x	14.1x	13.5x	12.1x	21.8x	11.7x	14.4x	13.2x
PBR	3.17x	2.86x	2.39x	1.62x	2.56x	2.31x	2.12x	1.94x
PEG	-	14.13x	-1.73x	-0.5x	-9.88x	0.1x	-0.8x	1.55x
Capitalization / Revenue	2.94x	2.77x	2.52x	1.78x	3.26x	2.75x	2.83x	2.66x
EV / Revenue	2.61x	2.44x	2.12x	1.51x	2.94x	2.46x	2.45x	2.22x
EV / EBITDA	9.5x	9.43x	8.39x	6.22x	12.1x	6.91x	9.13x	8.45x
EV / EBIT	10.7x	10.8x	9.77x	7.68x	15.6x	9.23x	11.4x	10.4x
EV / FCF	23.7x	14.1x	26.2x	17.5x	19.5x	11x	13.5x	10.2x
FCF Yield	4.22%	7.11%	3.82%	5.71%	5.12%	9.08%	7.42%	9.76%
Dividend per Share ²	0.18	0.21	0.28	0.26	0.29	0.3975	0.365	0.3789
Rate of return	2.13%	2.56%	3.86%	5.44%	3.44%	4.58%	4.2%	4.36%
EPS ²	0.5773	0.5831	0.5376	0.3946	0.3859	0.741	0.6051	0.6565
Distribution rate	31.2%	36%	52.1%	65.9%	75.2%	53.6%	60.3%	57.7%
Net sales ¹	34,309	35,292	34,175	31,046	29,533	36,144	35,125	37,343
EBITDA ¹	9,431	9,148	8,615	7,547	7,168	12,871	9,438	9,820
EBIT ¹	8,366	7,952	7,400	6,113	5,564	9,632	7,563	7,995
Net income ¹	6,901	6,949	6,382	4,632	4,409	8,294	6,844	7,413
Net Debt ¹	-11,298	-11,467	-13,738	-8,238	-9,670	-10,342	-13,087	-16,287
Reference price ²	8.470	8.200	7.260	4.780	8.430	8.685	8.685	8.685
Nbr of stocks (in thousands)	11,916,370	11,915,520	11,848,756	11,541,665	11,433,025	11,433,025	-	-
Announcement Date	3/22/22	3/22/23	3/20/24	3/28/25	3/25/26	-	-	-

¹HKD in Million²HKD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CSPC PHARMACEUTICAL GROUP LIMITED	11.88x	2.5x	7.01x	4.52%	12.83B
ELI LILLY AND COMPANY	35.07x	12.64x	25.79x	0.56%	1,093B
JOHNSON & JOHNSON	30.16x	-	-	1.98%	653B
ABBVIE INC.	33.05x	7.66x	15.93x	2.65%	458B
ROCHE HOLDING AG	20.11x	4.77x	11.83x	2.77%	355B
NOVARTIS AG	21.93x	5.66x	14.07x	2.83%	294B
ASTRAZENECA PLC	20.48x	4.23x	12x	2.08%	248B
AMGEN INC.	26.9x	6.98x	12.39x	2.37%	230B
NOVO NORDISK A/S	13.48x	4.8x	10.06x	3.81%	203B
GILEAD SCIENCES, INC.	-43.83x	6.34x	24.76x	2.3%	178B
Average	16.92x	6.18x	14.87x	2.59%	372.33B
Weighted average by Cap.	25.00x	8.29x	18.29x	1.94%